UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York

Gynecologic oncology, 2024-02, Vol.181, p.133-140

2024

Link zum Volltext

Verfügbarkeit prüfen

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

PloS one, 2015-12, Vol.10 (12), p.e0145754-e0145754

2015

Link zum Volltext

Verfügbarkeit prüfen

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Annals of surgical oncology, 2023-09, Vol.30 (9), p.5597-5609

2023

Link zum Volltext

Verfügbarkeit prüfen

The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York

Gynecologic oncology, 2018-04, Vol.149 (1), p.63-69

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Journal of ovarian research, 2019-04, Vol.12 (1), p.36-36, Article 36

2019

Link zum Volltext

Verfügbarkeit prüfen

A critical re-appraisal of BRCA1 methylation studies in ovarian cancer

Gynecologic oncology, 2010-11, Vol.119 (2), p.376-383

2010

Link zum Volltext

Verfügbarkeit prüfen

Challenges to Cancer Program Development in Low- and Middle-Income Countries

Annals of global health, 2016-07, Vol.82 (4), p.614-620

2016

Link zum Volltext

Verfügbarkeit prüfen

Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA

Neoplasia (New York, N.Y.), 2014, Vol.16 (1), p.97-W29

2014

Link zum Volltext

Verfügbarkeit prüfen

Nuclear distributions of NUP62 and NUP214 suggest architectural diversity and spatial patterning among nuclear pore complexes

PloS one, 2012-04, Vol.7 (4), p.e36137-e36137

2012

Link zum Volltext

Verfügbarkeit prüfen

Cervical Cancer Screening in Rural South Africa among HIV-infected Migrant Farm Workers and Sex Workers

Gynecologic oncology reports, 2017-05, Vol.20 (C), p.18-21

2017

Link zum Volltext

Verfügbarkeit prüfen

Platinum(II) Complex-Nuclear Localization Sequence Peptide Hybrid for Overcoming Platinum Resistance in Cancer Therapy

ACS biomaterials science & engineering, 2018-02, Vol.4 (2), p.463-467

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to the Letter to the Editor by Bol and van Diest regarding the review article “BRCA1 methylation and BRCA1 mutations in ovarian cancer”

Gynecologic oncology, 2011-08, Vol.122 (2), p.459-460

2011

Link zum Volltext

Verfügbarkeit prüfen

A classificação de Bethesda: uma análise morfométrica das biópsias do colo uterino

Revista Brasileira de Cancerologia, 2022-10, Vol.41 (4), p.251-256

2022

Link zum Volltext

Verfügbarkeit prüfen

Caracterização morfométrica das lesões do colo uterino relacionadas ao vírus da papilomatose humana

Revista Brasileira de Cancerologia, 2022-10, Vol.41 (4), p.243-250

2022

Link zum Volltext

Verfügbarkeit prüfen

Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

Journal of ovarian research, 2011-10, Vol.4 (1), p.18-18, Article 18

2011

Link zum Volltext

Verfügbarkeit prüfen

Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer

Journal of ovarian research, 2012-01, Vol.5 (1), p.4-4, Article 4

2012

Link zum Volltext

Verfügbarkeit prüfen

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer

Journal of ovarian research, 2012-01, Vol.5 (1), p.3-3, Article 3

2012

Link zum Volltext

Verfügbarkeit prüfen

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin bevacizumab, docetaxel and cyclophosphamide (GFIP/BDC) for heavily pretreated epithelial ovarian (EOC), Fallopian tube (FT) and primary peritoneal (PP) cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17073-e17073

2017

Link zum Volltext

Verfügbarkeit prüfen

The impact of nativity on uterine cancer survival in the two public hospitals in Queens, New York

Gynecologic oncology, 2021-08, Vol.162, p.S296-S297

2021

Link zum Volltext

Verfügbarkeit prüfen

Going virtual: increased uptake of gynecologic cancer support services post-COVID-19

Gynecologic oncology, 2021-08, Vol.162, p.S164-S165

2021

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase II trial with sacituzumab govitecan-hziy in patients with recurrent endometrial carcinoma overexpressing Trop-2

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5599-5599

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(102)

Sprache

Englisch
(102)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study

Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

A critical re-appraisal of BRCA1 methylation studies in ovarian cancer

Challenges to Cancer Program Development in Low- and Middle-Income Countries

Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA

Nuclear distributions of NUP62 and NUP214 suggest architectural diversity and spatial patterning among nuclear pore complexes

Cervical Cancer Screening in Rural South Africa among HIV-infected Migrant Farm Workers and Sex Workers

Platinum(II) Complex-Nuclear Localization Sequence Peptide Hybrid for Overcoming Platinum Resistance in Cancer Therapy

Response to the Letter to the Editor by Bol and van Diest regarding the review article “BRCA1 methylation and BRCA1 mutations in ovarian cancer”

A classificação de Bethesda: uma análise morfométrica das biópsias do colo uterino

Caracterização morfométrica das lesões do colo uterino relacionadas ao vírus da papilomatose humana

Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin bevacizumab, docetaxel and cyclophosphamide (GFIP/BDC) for heavily pretreated epithelial ovarian (EOC), Fallopian tube (FT) and primary peritoneal (PP) cancer

The impact of nativity on uterine cancer survival in the two public hospitals in Queens, New York

Going virtual: increased uptake of gynecologic cancer support services post-COVID-19

Preliminary results of a phase II trial with sacituzumab govitecan-hziy in patients with recurrent endometrial carcinoma overexpressing Trop-2

Suchergebnisse filtern